A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.

@article{Serretta2010A1M,
  title={A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.},
  author={Vincenzo Serretta and Giuseppe Morgia and Vincenzo Altieri and Alessandra Di Lallo and Giovanni Ruggiero and Luigi Salzano and Michele Battaglia and Mario Falsaperla and Aniello Zito and Domenico Sblendorio and Darvinio Melloni and Rosalinda Allegro},
  journal={BJU international},
  year={2010},
  volume={106 2},
  pages={212-7}
}
OBJECTIVE To evaluate the efficacy of 1-year maintenance after a 6-week cycle of early intravesical chemotherapy, as the role of maintenance in intravesical chemotherapy is debated. PATIENTS AND METHODS Between May 2002 and August 2003, 577 patients with non-muscle-invasive bladder cancer (NMI-BC) underwent transurethral resection (TUR) and early intravesical chemotherapy (epirubicin, 80 mg/50 mL). They were randomized between a 6-week induction cycle and the induction cycle plus maintenance… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…